Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-020322
Filing Date
2010-04-15
Accepted
2010-04-15 12:03:49
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v180861_10k.htm 10-K 1387907
2 GRAPHIC logo.jpg GRAPHIC 16871
3 v180861_ex31-1.htm EX-31.1 11300
4 v180861_ex31-2.htm EX-31.2 10971
5 v180861_ex32-1.htm EX-32.1 5378
6 v180861_ex32-2.htm EX-32.2 5392
  Complete submission text file 0001144204-10-020322.txt   1445961
Mailing Address 409 CALLE SAN PABLO SUITE 100-101 CAMARILLO CA 93010
Business Address 409 CALLE SAN PABLO SUITE 100-101 CAMARILLO CA 93010 805-484-7687
Huifeng Bio-Pharmaceutical Technology, Inc. (Filer) CIK: 0001119951 (see all company filings)

EIN.: 870650264 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32253 | Film No.: 10751173
SIC: 2833 Medicinal Chemicals & Botanical Products